Interleukin-17 inhibitors. A new era in treatment of psoriasis and other skin diseases

Psoriasis is a chronic skin disease caused by the excessive secretion of inflammatory cytokines. Available therapeutic options include biologic drugs such as tumor necrosis factor alpha inhibitors and interleukin 12/23 (IL-12/23) inhibitors. The recent discovery of IL-17, which contributes to develo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Postepy Dermatol Alergol
Hauptverfasser: Wasilewska, Agnieszka, Winiarska, Marta, Olszewska, Małgorzata, Rudnicka, Lidia
Format: Artigo
Sprache:Inglês
Veröffentlicht: Termedia Publishing House 2016
Schlagworte:
Review Paper
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5004212/
https://ncbi.nlm.nih.gov/pubmed/27605893
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/ada.2016.61599
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge